Vol. 4 No. 2 (2012)

Artigos

• Technology assessment of pegylated interferon and conventional interferon in combination with ribavirin for the treatment of genotype 1 chronic hepatitis C

  Cid Vianna, Gabriela Mosegui, Frances Valéria Silva, Antonio Augusto Peregrino, Marcus Paulo Rodrigues, Fernando Jardim

  364-372

  • PDF (Português (Brasil))

• Resource use and costs associated with treatment of idiopathic menorrhagia with intrauterine system releasing levonorgestrel (LNG-IUS) versus hysterectomy: the perspective of the health care system (SUS)

  Vanessa Teich, M. Valeria Bahamondes, Yuri de Lima, Natalia Santoni, Luis Bahamondes, Ilza Monteiro

  373-381

  • PDF (Português (Brasil))

• Cost-effectiveness analysis of pemetrexed + cisplatin versus paclitaxel + carboplatin versus paclitaxel + carboplatin + bevacizumab in patients with advanced non-small cell lung cancer without previous treatment

  Camila Souza, Luciano Paladini, Roberta Monteiro, Bernardo Paiva

  382-390

  • PDF (Português (Brasil))

• Determinants of expenditures with Brazilian citizens health care: a contribution from an empirical-quantitative study in whole territory

  Carlos Roberto Carmo, Vidigal Martins

  391-398

  • PDF (Português (Brasil))

• Cost-effectiveness analysis of caspofungin for empirical treatment of candidemia in patients after cardiac surgery

  Marcelo Correia, Graziele Cristine Silva, Braulio Santos, Helena Rey, Marisa Santos, Bernardo Tura

  399-405

  • PDF (Português (Brasil))

• Cost-minimization analysis of tadalafil in the treatment of pulmonary arterial hypertension under the perspective of the Brazilian Public Health Care System

  Bernardo Paiva, Roberta Monteiro, Roberta Fernandes, Maíra Takemoto

  406-412

  • PDF (Português (Brasil))

• Cost-effectiveness Analysis of FOLFOX followed by FOLFIRI versus 5-FU/LV followed by Irinotecan for metastatic colorectal cancer in the Brazilian Public Health Care System

  Adriana Carvalho, Emma Sasse, André Sasse

  413-419

  • PDF (Português (Brasil))